Carl Firth

CEO, ASLAN Pharmaceuticals

Founder and Chief Executive Officer of ASLAN Pharmaceuticals
Previously Head of Asia Healthcare at Bank of America Merrill Lynch
More than 10 years’ experience in commercial and R&D roles at AstraZeneca, including Regional Business Development Director AsiaPac and Director of New Product Development China
Holds a PhD from Cambridge University in Molecular Biology (Trinity College), an Executive MBA from London Business School and a degree in Molecular Biology from Cambridge University
Independent Director of Singapore’s Exploit Technologies
Adjunct Professor at Duke-NUS Medical School